Researchers in Ireland have retracted a case study about a rare type of cancer in a child because – contrary to what they claimed in the paper – they had not obtained the necessary permission from the parents.
In the June 2016 article, the authors stated they had received “written informed consent” from the parents to publish the case. But according to the retraction notice — issued just a few months later in October — that was not the case.
Here’s the retraction notice for “Paediatric Ewing-like sarcoma arising from the cranium – a unique diagnostic challenge,” which for legal reasons, the publisher has withdrawn from public view:
Continue reading Study of child with rare cancer retracted due to lack of parental consent
In a massive cleanup, Springer and BioMed Central announced today they are retracting 58 papers for several reasons, including manipulation of the peer-review process and inappropriately allocating authorship.
The papers appeared in seven journals, and more are under investigation.
In a release issued today, the publishers note: Continue reading Springer, BMC retracting nearly 60 papers for fake reviews and other issues
BioMed Central is investigating a recent paper about a potential biomarker for liver cancer, which shows signs it was written using another article as a template.
According to Jeffrey Beall, who exposed the similarities between the two papers on his blog Scholarly Open Access yesterday, the paper in question is “obviously bogus,” and appears to have relied on the “template plagiarism” technique of creating a new article by modifying a previous paper’s text and data.
A spokesperson for BioMed Central, which published the allegedly “junk” paper, as Beall calls it, told us they are looking into the allegations: Continue reading BMC investigating allegedly copied paper
Editors at BioMed Central have taken the unusual step of updating a retraction notice after an investigation found the authors were not responsible for a peer review process gone awry. The paper is one of dozens of other papers retracted in March for fake peer reviews.
That month, the paper “Clinical application of contrast enhanced ultrasound to diagnose benign prostatic hyperplasia” in Diagnostic Pathology was among the 43 papers retracted due to fake peer reviews. (Retractions for the phenomenon — more about it in our Nature feature here — are up to about 170.)
According to the update posted in July, an investigation into the paper by the Jiading Central Hospital in Shanghai, where the authors work, found that they “did not participate in influencing the peer review process.”
Here’s more from the update to the notice:
Continue reading BMC editors update retraction after investigation clears authors of faking peer reviews